Your browser doesn't support javascript.
loading
A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease.
Cardoso, Francisco; Goetz, Christopher G; Mestre, Tiago A; Sampaio, Cristina; Adler, Charles H; Berg, Daniela; Bloem, Bastiaan R; Burn, David J; Fitts, Michael S; Gasser, Thomas; Klein, Christine; de Tijssen, Marina A J; Lang, Anthony E; Lim, Shen-Yang; Litvan, Irene; Meissner, Wassilios G; Mollenhauer, Brit; Okubadejo, Njideka; Okun, Michael S; Postuma, Ronald B; Svenningsson, Per; Tan, Louis C S; Tsunemi, Taiji; Wahlstrom-Helgren, Sarah; Gershanik, Oscar S; Fung, Victor S C; Trenkwalder, Claudia.
Afiliação
  • Cardoso F; Movement Disorders Unit, Neurology Service, Internal Medicine Department, The Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Goetz CG; Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
  • Mestre TA; Ottawa Hospital Research Institute; University of Ottawa Brain and Mind Research Institute; Division of Neurology, Department of Medicine, University of Ottawa, The Ottawa Hospital Ottawa, Ottawa, Ontario, Canada.
  • Sampaio C; CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.
  • Adler CH; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
  • Berg D; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Bloem BR; Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel and Christian Albrechts-University of Kiel, Kiel, Germany.
  • Burn DJ; Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Department of Neurology, Center of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands.
  • Fitts MS; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Gasser T; UAB Libraries, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Klein C; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. German Center for Neurodegenerative Diseases, Tübingen, Germany.
  • de Tijssen MAJ; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Lang AE; Department of Neurology, Expertise Centre Movement Disorders, University Medical Centre Groningen, Groningen, The Netherlands.
  • Lim SY; Edmond J. Safra Program in Parkinson's Disease, University Health Network and the University of Toronto, Toronto, Ontario, Canada.
  • Litvan I; Division of Neurology, Department of Medicine, and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Meissner WG; Parkinson and Other Movement Disorders Center, Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
  • Mollenhauer B; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, Bordeaux, France.
  • Okubadejo N; Univ. Bordeaux, CNRS, IMN, Bordeaux, France.
  • Okun MS; Department of Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand.
  • Postuma RB; Department of Neurology, University Medical Center, Kassel, Germany.
  • Svenningsson P; Neurology Unit, Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Tan LCS; Adelaide Lackner Professor of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainsville, Florida, USA.
  • Tsunemi T; Department of Neurology, McGill University, Montreal Neurological Institute, Montreal, Quebec, Canada.
  • Wahlstrom-Helgren S; Section of Neurology, Karolinska Institutet, Stockholm, Sweden.
  • Gershanik OS; National Neuroscience Institute, Singapore.
  • Fung VSC; Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Trenkwalder C; International Parkinson and Movement Disorder Society, Milwaukee, Wisconsin, USA.
Mov Disord ; 39(2): 259-266, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38093469

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article